HIV infection increases cancer risk and is linked to cancers associated to infectious agents
classified as carcinogenic to humans by the International Agency for Research on Cancer …

The antiretroviral treatment (ART) developed to control HIV infection led to a revolution in the
prognosis of people living with HIV (PLWH). PLWH underwent from suffering severe disease …

Abstract Background Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently
limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell …

Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …

We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred
nine individuals with this variant had a 0.54 to 0.74 log10 increase (ie, a~ 3.5-fold to 5.5-fold …

Background: The HIV Prevention Trials Network (HPTN) 083 trial demonstrated the
superiority of long-acting injectable cabotegravir (CAB-LA) compared with oral emtricitabine …

Background This systematic review aimed to compare body weight gain associated
outcomes over time between dolutegravir (DTG)-based antiretroviral (ART) regimens to …

Abstract Background People with HIV (PWH) are at increased risk of severe COVID‐19. We
aimed to determine humoral responses in PWH and controls who received two doses of …

Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a …

Background Development of human immunodeficiency virus (HIV) remission strategies
requires precise information on time to HIV rebound after treatment interruption, but there is …